OPTIMIZERX CORP (OPRX) Stock Fundamental Analysis

NASDAQ:OPRX • US68401U2042

8.75 USD
+0.54 (+6.58%)
At close: Feb 13, 2026
8.75 USD
0 (0%)
After Hours: 2/13/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

Taking everything into account, OPRX scores 6 out of 10 in our fundamental rating. OPRX was compared to 35 industry peers in the Health Care Technology industry. OPRX has an average financial health and profitability rating. OPRX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year OPRX was profitable.
  • In the past year OPRX had a positive cash flow from operations.
  • In the past 5 years OPRX reported 4 times negative net income.
  • In multiple years OPRX reported negative operating cash flow during the last 5 years.
OPRX Yearly Net Income VS EBIT VS OCF VS FCFOPRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

  • OPRX has a Return On Assets of 0.02%. This is in the better half of the industry: OPRX outperforms 74.29% of its industry peers.
  • The Return On Equity of OPRX (0.03%) is better than 74.29% of its industry peers.
  • OPRX has a Return On Invested Capital of 3.51%. This is in the better half of the industry: OPRX outperforms 68.57% of its industry peers.
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROIC 3.51%
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
OPRX Yearly ROA, ROE, ROICOPRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • With a decent Profit Margin value of 0.03%, OPRX is doing good in the industry, outperforming 74.29% of the companies in the same industry.
  • The Operating Margin of OPRX (6.17%) is better than 71.43% of its industry peers.
  • With a Gross Margin value of 65.31%, OPRX perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • OPRX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.17%
PM (TTM) 0.03%
GM 65.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
OPRX Yearly Profit, Operating, Gross MarginsOPRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OPRX is destroying value.
  • OPRX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for OPRX has been increased compared to 5 years ago.
  • The debt/assets ratio for OPRX has been reduced compared to a year ago.
OPRX Yearly Shares OutstandingOPRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
OPRX Yearly Total Debt VS Total AssetsOPRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • OPRX has an Altman-Z score of 2.26. This is not the best score and indicates that OPRX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • OPRX's Altman-Z score of 2.26 is fine compared to the rest of the industry. OPRX outperforms 68.57% of its industry peers.
  • OPRX has a debt to FCF ratio of 2.43. This is a good value and a sign of high solvency as OPRX would need 2.43 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.43, OPRX is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • A Debt/Equity ratio of 0.20 indicates that OPRX is not too dependend on debt financing.
  • OPRX's Debt to Equity ratio of 0.20 is on the low side compared to the rest of the industry. OPRX is outperformed by 60.00% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for OPRX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.43
Altman-Z 2.26
ROIC/WACC0.32
WACC10.95%
OPRX Yearly LT Debt VS Equity VS FCFOPRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 3.05 indicates that OPRX has no problem at all paying its short term obligations.
  • With a Current ratio value of 3.05, OPRX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • A Quick Ratio of 3.05 indicates that OPRX has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.05, OPRX is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 3.05
OPRX Yearly Current Assets VS Current LiabilitesOPRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 182.76% over the past year.
  • OPRX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 101.23% yearly.
  • OPRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.18%.
  • OPRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.22% yearly.
EPS 1Y (TTM)182.76%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%66.67%
Revenue 1Y (TTM)24.18%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%22.33%

3.2 Future

  • Based on estimates for the next years, OPRX will show a very strong growth in Earnings Per Share. The EPS will grow by 48.06% on average per year.
  • OPRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.83% yearly.
EPS Next Y131.3%
EPS Next 2Y64.77%
EPS Next 3Y48.06%
EPS Next 5YN/A
Revenue Next Year19.98%
Revenue Next 2Y15.57%
Revenue Next 3Y13.83%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OPRX Yearly Revenue VS EstimatesOPRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
OPRX Yearly EPS VS EstimatesOPRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • OPRX is valuated reasonably with a Price/Earnings ratio of 10.67.
  • 94.29% of the companies in the same industry are more expensive than OPRX, based on the Price/Earnings ratio.
  • OPRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.97.
  • The Price/Forward Earnings ratio is 9.77, which indicates a very decent valuation of OPRX.
  • Based on the Price/Forward Earnings ratio, OPRX is valued cheaper than 85.71% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, OPRX is valued rather cheaply.
Industry RankSector Rank
PE 10.67
Fwd PE 9.77
OPRX Price Earnings VS Forward Price EarningsOPRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • OPRX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. OPRX is cheaper than 62.86% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of OPRX indicates a rather cheap valuation: OPRX is cheaper than 82.86% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.1
EV/EBITDA 14.57
OPRX Per share dataOPRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • OPRX's earnings are expected to grow with 48.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)0.11
EPS Next 2Y64.77%
EPS Next 3Y48.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for OPRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OPTIMIZERX CORP

NASDAQ:OPRX (2/13/2026, 8:00:02 PM)

After market: 8.75 0 (0%)

8.75

+0.54 (+6.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-06
Earnings (Next)03-05
Inst Owners75.22%
Inst Owner Change-0.12%
Ins Owners12.92%
Ins Owner Change1.22%
Market Cap163.10M
Revenue(TTM)109.51M
Net Income(TTM)32.00K
Analysts83.08
Price Target24.82 (183.66%)
Short Float %10.47%
Short Ratio6.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)807.75%
Min EPS beat(2)342.72%
Max EPS beat(2)1272.78%
EPS beat(4)4
Avg EPS beat(4)447.32%
Min EPS beat(4)8.43%
Max EPS beat(4)1272.78%
EPS beat(8)7
Avg EPS beat(8)250.62%
EPS beat(12)10
Avg EPS beat(12)191.95%
EPS beat(16)13
Avg EPS beat(16)147.27%
Revenue beat(2)2
Avg Revenue beat(2)17.89%
Min Revenue beat(2)7.23%
Max Revenue beat(2)28.56%
Revenue beat(4)4
Avg Revenue beat(4)13.8%
Min Revenue beat(4)4.37%
Max Revenue beat(4)28.56%
Revenue beat(8)6
Avg Revenue beat(8)4.84%
Revenue beat(12)8
Avg Revenue beat(12)2.3%
Revenue beat(16)8
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)24.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.8%
EPS NY rev (1m)0%
EPS NY rev (3m)12.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.56%
Valuation
Industry RankSector Rank
PE 10.67
Fwd PE 9.77
P/S 1.49
P/FCF 14.1
P/OCF 13.79
P/B 1.33
P/tB 18.21
EV/EBITDA 14.57
EPS(TTM)0.82
EY9.37%
EPS(NY)0.9
Fwd EY10.24%
FCF(TTM)0.62
FCFY7.09%
OCF(TTM)0.63
OCFY7.25%
SpS5.87
BVpS6.56
TBVpS0.48
PEG (NY)0.08
PEG (5Y)0.11
Graham Number11
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROCE 4.45%
ROIC 3.51%
ROICexc 4.03%
ROICexgc 28.04%
OM 6.17%
PM (TTM) 0.03%
GM 65.31%
FCFM 10.56%
ROA(3y)-9.94%
ROA(5y)-6.64%
ROE(3y)-13.38%
ROE(5y)-8.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.49%
GM growth 5Y0.53%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.43
Debt/EBITDA 2.24
Cap/Depr 5.95%
Cap/Sales 0.24%
Interest Coverage 1.25
Cash Conversion 106.61%
Profit Quality 36153.1%
Current Ratio 3.05
Quick Ratio 3.05
Altman-Z 2.26
F-Score7
WACC10.95%
ROIC/WACC0.32
Cap/Depr(3y)19.52%
Cap/Depr(5y)17.6%
Cap/Sales(3y)0.7%
Cap/Sales(5y)0.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)182.76%
EPS 3Y-9.14%
EPS 5Y101.23%
EPS Q2Q%66.67%
EPS Next Y131.3%
EPS Next 2Y64.77%
EPS Next 3Y48.06%
EPS Next 5YN/A
Revenue 1Y (TTM)24.18%
Revenue growth 3Y14.55%
Revenue growth 5Y30.22%
Sales Q2Q%22.33%
Revenue Next Year19.98%
Revenue Next 2Y15.57%
Revenue Next 3Y13.83%
Revenue Next 5YN/A
EBIT growth 1Y156.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.66%
EBIT Next 3Y53.84%
EBIT Next 5YN/A
FCF growth 1Y115790%
FCF growth 3Y154.28%
FCF growth 5YN/A
OCF growth 1Y549.84%
OCF growth 3Y88.49%
OCF growth 5YN/A

OPTIMIZERX CORP / OPRX FAQ

What is the ChartMill fundamental rating of OPTIMIZERX CORP (OPRX) stock?

ChartMill assigns a fundamental rating of 6 / 10 to OPRX.


Can you provide the valuation status for OPTIMIZERX CORP?

ChartMill assigns a valuation rating of 8 / 10 to OPTIMIZERX CORP (OPRX). This can be considered as Undervalued.


How profitable is OPTIMIZERX CORP (OPRX) stock?

OPTIMIZERX CORP (OPRX) has a profitability rating of 4 / 10.


How financially healthy is OPTIMIZERX CORP?

The financial health rating of OPTIMIZERX CORP (OPRX) is 6 / 10.


What is the earnings growth outlook for OPTIMIZERX CORP?

The Earnings per Share (EPS) of OPTIMIZERX CORP (OPRX) is expected to grow by 131.3% in the next year.